Cite

HARVARD Citation

    Chen, M. et al. (2016). A Phase II Study of Sequential Capecitabine Plus Oxaliplatin Followed by Docetaxel Plus Capecitabine in Patients With Unresectable Gastric Adenocarcinoma. Medicine. 95 (3), p. . [Online]. 
  
Back to record